Showing results (271-280 of 344) with videos related to

Sort By:
Pageof 35
Alimentary Pharmacology & Therapeutics|March 2, 2022
Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairmentMark Sulkowski, Laura E Telep, Massimo Colombo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 1, 2013
Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasoundMarzia Galassi, Massimo Iavarone, Sandro Rossi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 20, 2022
Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis: A prospective single center studyMassimo Iavarone, Giulia Tosetti, Floriana Facchetti, et al.
Seminars in Liver Disease|July 10, 2018
The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational ConsiderationsJeffrey V Lazarus, Kelly Safreed-Harmon, Mark R Thursz, et al.
JHEP Reports : Innovation in Hepatology|April 6, 2026
Impact of Hepatocellular Carcinoma on the risk of liver decompensation: a comparative analysis of patients with and without HCC: Role of HCC in liver decompensationAndrea Martini, Massimo Iavarone, Roberta D'Ambrosio, et al.
Journal of Viral Hepatitis|January 17, 2025
DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral TherapyAmit G Singal, K Rajender Reddy, Massimo Colombo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 25, 2021
Long-term Patient-Centered Outcomes in Cirrhotic Patients With Chronic Hepatitis C After Achieving Sustained Virologic ResponseZobair M Younossi, Andrei Racila, Andrew Muir, et al.
Hepatology Communications|March 8, 2021
A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCCRoniel Cabrera, Amit G Singal, Massimo Colombo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 11, 2025
Management of Hepatitis B virus infection in patients on treatment with immunosuppressants or immunomodulators: Position Paper of Associazione Italiana Studio del Fegato (AISF), Associazione Italiana di Oncologia Medica (AIOM), Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO), Società Italiana di Reumatologia (SIR), Società Italiana Trapianti d'Organo (SITO), Società Italiana di Gastroenterologia (SIGE), Società Italiana di Malattie Infettive e Tropicali (SIMIT)Mauro Viganò, Roberta D'Ambrosio, Ciro Celsa, et al.
American Journal of Hematology|September 21, 2017
Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathiesRaffaella Origa, Maria Laura Ponti, Aldo Filosa, et al.
Pageof 35